CAPLIPOINTNSECAPLIN POINT LAB LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 2 Sept, 2026 · 17:29 IST

Caplin Point clarifies unusual trading volume, says no hidden info

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.2%Reaction day
₹2720.20
prior close
₹2712.00
announcement price
After-mkt
timing
Nifty Smallcap 250market+1.0%+3.2% vs market
Pharmaceuticals peers, median of 172sector+0.3%+3.9% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Smallcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
+0.6
15m
+0.6
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.2+1.0+3.2+0.3+3.9
Next day
+2.6+1.2+1.4+0.2+2.4
2d
+4.0+1.2+2.7+0.8+3.2
3d
+2.0+1.5+0.5+1.1+0.9
4d
-0.3+1.0-1.2+0.8-1.1
5d
+2.6+1.0+1.7+0.8+1.9
1w
-5.4-2.0-3.5-1.0-4.4
15d
+4.2-0.5+4.8+0.8+3.5
1m
-4.9-3.3-1.6-2.1-2.8
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE asked Caplin Point Laboratories to clarify a recent surge in its share trading volume. The company replied that all required disclosures under SEBI LODR regulations have been made, no price-sensitive information has been withheld, and the volume rise is purely market-driven with no specific reason known to the company.

Likely market impact

Routine volume clarification. No company-specific trigger found; price movement appears market-driven.